Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) Injection, Powder, Lyophilized, For Suspension
Product Images NDC 24979-710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) (NDC 24979-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Slowly Inject The 20 mL Of 0.9% Sodium Chloride Injection, Usp, Over A Minimum Of 1 Minute, Using The Sterile Syringe To Direct The Solution Flow Onto The Inside Wall Of The Vial. (Pacli 01)

FDA Label Image

Structural Formula For Paclitaxel (Pacli 02)

FDA Label Image

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Pacli 03)

FDA Label Image

Principal Display Plan (100mg Vial)

Principal Display Plan (100mg Vial)
Paclitaxel protein-bound is a medication given in injectable suspension form containing albumin-bound particles. Each vial contains 100mg of the drug. The product is manufactured by Abraxane and has the National Drug Code of 24979-710-51. Dosage and administration instructions are not available.*
FDA Label Image

Principal Display Panel (100 mg Vial)

Principal Display Panel (100 mg Vial)
This is a description of a medication called "Pacitaxel Protein-Bound Particles for Injectable Suspension" with a strength of 100mg per vial. It is a type of albumin-bound medication used for treatment purposes. The text also mentions the name "Satsevi" and some unidentifiable numbers. The last line is unclear and the text overall is incomplete and difficult to interpret.*
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
This is a medication label for an injectable suspension called "Paclitaxel Protein-Bound." The package contains a vial with 100 mg of the suspension, which should be reconstituted with 20 mL of 0.9% Sodium Chloride Injection, USP. The suspension contains particles, is temperature-sensitive, and should be carefully read for instructions to avoid errors. The text also contains a lot of garbled characters, and the was not successful in decoding some parts of the label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.